A B S T R A C T L-Thyroxine is converted to 3,5,3'-Ltriiodothyronine (T3) as well as to 3,3',5'-L-triiodothyronine (reverse T3). One product of further deiodination is 3,3'-diiodothyronine (3,3'T2). The serum levels of reverse T3 and 3,3'T2 change considerably in various physiological and disease states. We previously found that reverse T3 and 3,3'T2 bind to the solubilized hepatic nuclear "receptors" for thyroid hormones. This led us to study binding and actions of these metabolites in cultured rat pituitary cells in which glucose consumption and growth hormone production are regulated by T3 and Lthyroxine.
INTRODUCTION
Monodeiodination of thyroxine (3,5,3',5 '-tetraiodo-Lthyronine, T4)l in peripheral tissues results in the production of 3,3',5'-L-triiodothyronine (reverse T3) as well as the biologically potent 3,5,3'-L-triiodothyronine (T3, references [1] [2] [3] [4] [5] [6] . Studies in several laboratories have also shown that reverse T3 is a normal component of human serum (5) (6) (7) (8) (9) (10) (11) . Marked elevations of serum reverse T3, as compared with normal adult levels, have been found in the cord blood of newborn humans (with high concentrations also present in amniotic fluid) and in adult serum in various disease states, including hepatic cirrhosis, chronic renal failure, acute febrile disease, and protein and calorie malnutrition (5) (6) (7) (9) (10) (11) .
Elevations of reverse T, are frequently accompanied by a decrease in serum T3 (7, 10) . 3,3'-diiodo-Lthyronine (3,3'T2) is also a constituent of the serum iodothyronines, and its main source seems to be extrathyroidal (12) . 3,3'T2 is probably the major product of monodeiodination of reverse T3 and may only be a minor product of T3 metabolism (13) .
These recent observations relating to reverse T3 and 3,3'T2 have directed attention to possible biological functions of these compounds. In earlier studies (14) , reverse T3 appeared to have antithyroid hormonelike properties with respect to regulation of calorigenesis. By contrast, Samuels et al. (15) found that reverse T3 stimulated glucose consumption in cultured rat pituitary tumor cells (GHC). However, these workers could not exclude the possibility that their results were owing to the presence of contaminating T3. In some studies (16, 17) , reverse T3 was shown to possess as much as 5% the activity of T4 in preventing the development of goiter in rats receiving propylthiouracil; in other studies (18) , reverse T3 was reported to have <3% of the T4 goiter prevention or calorigenic action. In adult mouse hemopoietic cells, reverse T3 had 200 and 100% the activity of T3 and T4, respectively, in potentiating the effect of erythropoietin (19) . More recently, Chopra et al. (20, 21) reported that reverse T3 had a weak effect (5.2% that of T4) on the rat pituitary in suppressing the release of thyroid stimulating hormnone in response to thyrotropin releasing factor. The potential actions of 3,3'T2 have received less attention, and the available literature (16, 17, 22, 23) does not clearly define its intrinsic biological activity. In this discussion, we have excluded a review of actions of reverse T3 and 3,3'T2 in a number of potentially important systems in which the effects of T3 and T4 are observed only at hormone concentrations much greater than are achieved physiologically (24, 25) .
We recently found that both reverse T3 and 3,3'T2 bind to the putative nuclear receptors for thyroid hormones in studies with solubilized preparations (26) . These findings suggested that these substances could have intrinsic agonist or antagonist actions on thyroid hormone responses, and led us to study these metabolites in greater detail.
For the current studies we used cultured rat pituitary tuLmor cells (GH, line) that contain thyroid hormone receptors (27, 28) and respond to thyroid hormones by increases in glucose consumption (15) and growth hormone production (29) , and by decreases in prolactin production (29) . We also investigated another subline of these cells (GC) which differs from GH1 cells in that the former divide more frequently (mean doubling time of 30 h as compared with 48 h for the GHC cells), produce more growth hormone, do not produce a significant amount of prolactin, and can be grown readily in spinner culture (30) .
METHODS
Materials. Reverse T3 and 3,3'T2 were kindly provided by Dr. Eugene Jorgensen of the University of California at San Francisco. The synthesis and analysis of these compounds have been reported previously (31, 32) , and each migrated as a single peak in the thin-layer chromatography systems described earlier (26) . Stock solutions were prepared in n-propanol at 1 mM. Exposure of the solutions to UV irradiation was avoided. T3 was purchased from Sigma Chemical Co., (St. Louis, Mo.) and assayed for purity as previously described (26 25 ,ul (1 mg/ml) of Na2S205 was added. After mixing, an excess of KI (75 ,ul, 10 mg/ml) and 5 ml of hypophysectomized dog plasma (obtained from the Department of Physiology, University of California, San Francisco) were added, and this reaction mixture was applied to a Sephadex G-100 column (1.5 x 24 cm), equilibrated in BSA-barbital buffer (0.5 M barbital, pH 8.6, 5 mg/ml of BSA. The peak of 1251-growth hormone eluted at 1.8 times the void volume of the column, well separated from aggregation products (in the void volume) and free iodide (in the included volume, 2.5 times the void volume). The 125I1 growth hormone was diluted to a sp act of 400,000 cpm/ml with BSA-barbital buffer and then frozen at -60°C in 5-or 10-ml portions.
For the standard curve, duplicate 180-,ud aliquots containing from 0.5 to 6 ng growth hormone were added to 120-,u aliquots consisting of a 1:1 mixture of 1251_ growth hormone and first antibody (previously diluted 1: 10,000 or 1: 15,000 in BSA-barbital buffer). In all cases, the unknown samples were prepared and assayed in triplicate. After 4 days of incubation at 0-4°C, each tube received 240 ,l second antibody solution (previously diluted 1:20 in BSA-barbital buffer) and 60 ul carrier serum (previously diluted 1:25 in BSA-barbital buffer). After overnight incubation at 0-4°C, the tubes were centrifuged at 1,000 g for 30 min, and radioactivity in the pellets was assayed in a gamma spectrometer (efficiency 74%). The quantity of growth hormone in the unknown samples was calculated after comparison with a standard curve.
Under the conditions described, the assay was sensitive between 0.5 and 5 ng. From 60-70% of the radioactivity in the tubes that did not contain any unlabeled hormone was precipitated under the conditions of the assay. The intra-assay variation (36) was 2.9%.
Nuclear binding of T3, reverse T3 and 3,3'T2. Nuclear binding of T3, reverse T3, and 3,3'T2 was examined in serum-free and serum-containing media in GC cells, according to techniques previously described by Samuels and Tsai (27) . For serum-free experiments, GC cells in suspension culture (5 (37) . This method gives a cross-reactivity with T3 of <0.01%, with 3,3'T2 of 3.8%, and with T, of 0.062% (37) .
Metabolism of reverse T3.
[1251]Reverse T3 was incubated with cells and media as described in the legend to Table I . After the incubations, the media were collected and cells were detached by trypsinization as described above. The cells were then centrifuged (300g for 5 min) and the pellets were washed once with 3 ml of ice-cold phosphate-buffered saline and then frozen. After thawing, media samples were extracted with an equal volume of ethanol:butanol 1:3 (vol/vol) and the pellets (containing about 8 x 106 cells) were each extracted with 0.5 ml of the ethanol:butanol solution. After addition of the solvent, the mixtures were vigorously agitated and then centrifuged (5,000g, 10 min), and samples of the organic phase were analyzed by thin-layer chromatography as described previously (26) Different results were obtained when incubations were performed in serum-containing media (Fig. 2) Table I . Both reverse T3 and 3,3T2 stimulate glucose consumption (Figs. 3-5) . Concentrations of reverse T3 1,000-fold higher than T3 are required to produce equivalent effects (Figs. 3-5 ), although concentrations of 3,3'T2 one-hundredth that of reverse combination did not result in effects significantly greater than those elicited by maximally effective concentrations of T3 alone. The data in Fig. 6 and Table I show that reverse T3 can also stimulate growth hormone production by GC cells and also does not inhibit the effect of T3.
The three analogues were also found to stimulate growth hormone production in experiments with serum-free media ( Fig. 7 and Table I ). The stimulations, especially with T3 and reverse T3, were obtained at analogue concentrations lower than required for equivalent stiimulation in serum-cointaining media. The differences in the relative analogue potencies between the serum-free and serum-containing experiments cai1, in part, be explained by the varying binding of T3, reverse T3, and 3,3'T2 to the serum proteins (39 media as reverse T3 and 3,3'T2 was then quantified utilizing the thin-layer system previously described (26; Inasmuch as about 70% of the cell-associated radioactivity is accounted for by 3,3'T2, reverse T3, and iodide due to monodeiodination of reverse T3 to 3,3'T2, further deiodination products represent a minority of the thyronines associated with the cells. The data further suggest that the conversion of reverse T3 to 3,3'T2 is largely a cellular function, because there was little conversion of reverse T3 to 3,3'T2 when reverse T3 was incubated for 3 days in media without cells (Table II) .
DISCUSSION
In the present studies we utilized rat pituitary tumor cells to study nuclear binding and biological actions of T3, reverse T3, and 3,3'T2 as well as cellular metabolism of reverse T3. We confirmed the findings of Samuels and co-workers (15) that GH, cells respond to physiological concentrations of T3 by increased glucose consumption and growth hormone production. We also found that the GC line responds in a similar manner. In general agreement with Samuels' results (15, 29) , the maximally effective T3 concentration was in the range of 5 nM in serum-containing experiments, and T3 effects were observed at lower concentrations of the hormone (e.g., 0.1 nM) in experiments with serum-free medium. We also found that reverse T3 and 3,3'T2 stimulated glucose consumption and growth hormone production in both cell lines. Because the maximal responses elicited by either metabolite were as great as those of T3, and because a small additive effect was observed when reverse T3 was combined with submaximal concentrations of T3, it appears that both analogues behave as thyroid hormone agonists rather than antagonists. These data also suggest that the measured biological effects of reverse T3 and 3,3'T2 are probably mediated via the same mechanism as are those of T3.
The hypothesis that reverse T3 and 3,3'T2 actions are mediated by the intranuclear thyroid hormone receptor also receives some support from our previous studies (and those of Jorgensen and co-workers [23] ), with the solubilized thyroid hormone receptors from liver in which reverse T3 and 3,3'T2 were shown to competitively inhibit binding of radioactive T3 by the receptors. In the current studies, we found that reverse T3 and 3,3'T2 also compete with radioactive T3 for binding to the nuclear sites in GC cells in experiments where incubations were performed using intact cells.
Inasmuch as these results could be obtained if the initial preparations of reverse T3 and 3,3'T2 were contaminated with T3 or T4, it is crucial to know that this is not the case. A number of considerations suggest that contaminations do not explain the results
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Papavasiliou, Martial, Latham, and Baxter obtained. With respect to the reverse T3 sample, radioimmunoassay showed no T3 immunoreactive material under conditions in which 0.1 nM T3 is readily detectable. Second, the technique of Block (32) excludes such contaminants. Even with the method of Shiba and Cahnmann (31),3 it is extremely unlikely that the material was contaminated by as much as even 1% T3. T4 also does not appear to be present in the reverse T3 preparations, because the 25% contamination required to explain the previous receptor binding data (26) would have been detected by our thin-layer chromatography analysis as described previously (26) . This level of contamination is also excluded by the elemental analysis of the material (31) . Although T4 radioimmunoassay might further clarify this issue, the antibodies to T4 do significantly cross-react with the reverse T3 preparations (26) have been readily detected by our thin-layer chromatography, and cannot explain the biological responses of 3,3'T2, because the relative potency of the preparation is greater in serum-containing than in serumfree media (Figs. 3 and 7) . Thus, we consider it to be unlikely that the results were the result of contamination of either reverse T3 or 3,3'T2 preparations with either T3 or T4. Some earlier preparations have recently been shown by high pressure gas-liquid chromatography to contain unidentified contaminants.5 These impurities are not T3 or T4 and were not detected in the preparations used in our present experiments. The presence of contaminants could explain why, in previous studies (26), we found a higher affinity for the solubilized receptors than was found in the present studies for receptors in either intact cells or solubilized preparations (Table I) . We found that the biological activity and the binding of 3,3'T2 relative to T3 was less in experiments in which serum-free medium was used than in experiments in which serum-containing medium was used. These differences could be explained if 3,3'T2 does not bind as avidly to serum as T3; this was found to be the case with human thyroxine-binding globulin (39), but was not directly studied in our situation for calf serum. Thus, a greater proportion of the circulating 3,3'T2 could be available for receptor binding and hormone action than T3 or T4.
The quantitative aspects of reverse T3 action were found to be more complex. Reverse T3 readily inhibited T3 binding in incubations with serum-free medium, but in fact stimulated binding of radioactive T3 in incubations with serum-containing medium. These data may be explained if reverse T3 binds more avidly to serum but less avidly to the receptor than T3. It is known that human serum binds reverse T3 more avidly than T3 (39 Avid plasma binding can account for the greater biological activity of reverse T3 in serum-free as com- 5 Jorgensen, E. C. Personal communication.
pared to serum-containing medium. Furthermore, the biological activity of reverse T3 relative to T3 and 3,3'T2 in general parallels its relative affinity for the intranuclear receptors. However, we found also that there was major cellular conversion of reverse T3 to 3,3'T2. In fact, only 12-18% ofthe cell-associated radioactivity was recovered as reverse T3; most of the hormone (60-66%) was recovered as 3,3'T2. By contrast, there was very little deiodination of reverse T3 in incubations with media only. Therefore, it seems that in the intracellular environment, most of the reverse T3 is converted to 3,3'T2. Consequently, 3,3'T2 may be a major form of the hormone in the cell available for receptor occupancy. In certain respects, then, reverse T3 may act as a prohormone being converted to 3,3'T2 intracellularly. These data also indicate that most of the cell-associated 3,3'T2 can remain in an unmetabolized form for an appreciable time period.
To quantify precisely the contribution of 3,3'T2 to reverse T3 action would require a direct measurement of radioactive reverse T3 and 3,3'T2 on the receptor under the exact conditions in which the inductions are performed. This is difficult in practice because the affinity of these analogues for the receptor is much lower than that of T3. Thus, there would be greater dissociation of these analogues during the isolation of nuclei, and more importantly, the higher concentrations of analogue required to produce adequate saturation of the receptors results in unacceptably high levels of nonspecific binding which masks an ability to directly observe specific binding.
These results, taken together, suggest that reverse T3 and 3,3'T2 can interact with the intranuclear receptors for thyroid hormone and influence thyroid hormone-mediated functions as agonists. The results also indicate that the quantitative aspects are complex and are influenced by serum binding and intracellular metabolism. Because thyroxine-binding globulin levels may vary, because target cells may vary in the extent to which reverse T3 is metabolized, and because there may be intratissue variations in the affinity of T3 and analogues for the receptors, caution must be excercised in transferring the quantitative aspects of the current studies to physiological situations. Nevertheless, it may be useful, for perspective and development of testable hypotheses, to use the available data, to ask to what extent could reverse T3 and 3,3'T2 influence thyroid hormoneregulated functions in the various states in which these hormones have been measured. Inasmuch as serum shifts the response to higher hormone concentrations, levels of 3,3'T2 or reverse T3 required for responses in vivo would probably be higher than those required in the current studies, in which 10% or no serum was present in the incubations. Levels of 3,3T2
Actions of Reverse T3 a nd 3,3'T2have been measured in amniotic fluid and in the serum of normal adults, in cord blood of the new born, and in patients with hypothyroidism, hyperthyroidism, and cirrhosis (42, 43) . Based on the current studies, the levels of 3,3'T2 in these situations are probably too low (0.1-0.6 nM) for more than minimal thyroid hormone agonist activity to be attributed to this compound. In the adult, in conditions of excess reverse T3 (e.g., cirrhosis, acute febrile disease, etc. [5] [6] [7] [8] [9] [10] [11] ), serum levels of the hormone rarely exceed 75 ng/dt (1.2 nM), although levels to 300 ng/dl have been detected in the human fetus (5) . The current studies show that even in undiluted plasma, reverse T3 is essentially inactive at this concentration. In amniotic fluid, reverse T3 levels may exceed 300 ng/dl (-5 nM). In this circumstance, reverse T3 may be mostly free, and therefore its levels may approach 5 nM in cellular compartments. At 5 nM (Fig. 1) , reverse T3 can minimally influence T3 binding to the receptors. Although the data raise the possibility that under certain circumstances, reverse T3 and 3,3'T2 may be active hormones, it is likely that these two hormones are mostly of minor importance in eliciting physiological responses of thyroid hormones.
